PCR Market: 2012 Polymerase Chain Reaction Market Needs, Emerging Developments and Future Use

ReportsnReports.com adds new market research report “PCR 2012: Market Needs, Emerging Developments and Future Use” to its store.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Dallas, TX (PRWEB) September 04, 2012

This study involved the participation of more than 600 experienced PCR users and decision-makers in 75 countries. It investigated PCR methods, companies and products, their strengths and weaknesses, current and future annual budgets, budget breakdown, consumables, challenges, innovation, biomarkers, bioinformatics software, sample preparation, quality control guidelines and other areas. As part of this study, PCR customers provided details of their anticipated purchases from suppliers in this field, over the period 2012 – 2015.

Key Findings

  •     Routine use: Use of PCR by end-users for running routine (developed and validated) PCR tests, the development or validation of PCR tests and for the qualitative discovery using PCR methods
  •     Companies: Purchases of PCR and related systems by end-users from more than 25 companies and anticipated PCR purchases by end-users from more than 25 companies over the next three years, each ranked according to their competitive position.
  •     PCR Methods: Current use of more than 30 PCR techniques by end-users and the anticipated use of these techniques by end-users over the next three years, each ranked according to their competitive position.
  •     PCR Application: Current use of 12 leading PCR applications by end-users and the anticipated use of these applications by end-users over the next three years, each ranked according to their competitive position.
  •     Preferred Companies: End-users’ preferred companies in the PCR field, each ranked according to their competitive position.
  •     Products: End-users’ preferred products (and associated companies) in the PCR field, each ranked according to their competitive position.
  •     Strengths: End-users’ disclosures of the strengths of their preferred products in the PCR field, each ranked according to their competitive position.
  •     Weaknesses: End-users’ disclosures of the weaknesses of their preferred products in the PCR field, each ranked according to their relative position.
  •     Current Financial Budgets: End-users’ annual financial budgets for PCR studies.
  •     Current Budget Breakdown: The breakdown of end-users’ PCR financial budgets in eight key areas, relating to their current expenditure on PCR products and activities.
  •     Future Budget Breakdown: The breakdown of end-users’ PCR financial budgets in eight key areas, relating to their anticipated expenditure over the next three years, on PCR products and activities.
  •     Future Financial Budgets: End-users’ anticipated changes (percentage increases or decrease) over the next three years, relating to their PCR activities
  •     Consumables: End-users’ top three consumables, associated with their PCR activities.
  •     Quality Control Guidelines: End-users’ adherence to established quality control guidelines or procedures, relating to the conduct of PCR studies.
  •     Current Challenges: End-users’ disclosures on molecular types that present the greatest technical challenges to PCR analysis, together with the associated sample types (matrices), associated PCR methods and underlying reasons.
  •     Innovation: End-users’ current needs relating to 12 key areas of required innovation in the PCR field, each ranked (on a scale of 1 to 10) according to their importance.
  •     Recent Innovations: End-users disclosures on the most important innovations relating to their use of PCR, over the last three years.
  •     Future Innovation: End-users’ disclosures on what they anticipate will be the most important innovations in the PCR field, over the next three years.
  •     Biomarkers: End-users’ application of PCR methods for the study of disease biomarkers, including molecular types and their clinical utilities.
  •     Organisations: End-users organisations include clinics or hospitals, government bodies, large international companies, research institutes, small and medium sized companies, universities and veterinary centres.
  •     Fields: End-users underlying fields include biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security and universities.
  •     Bioinformatics Software: End-users’ disclosures on their preferred bioinformatics software, associated with PCR studies.
  •     Purpose: End-users’ underlying reasons for using PCR analysis across 13 major fields (biotechnology, chemicals, clinical or hospital, defence, energy, environmental, food and drink, forensics, geology, government, healthcare, natural products, pharmaceuticals, research institutes, security, university), each ranked according to their relative importance.
  •     Study Samples: Study sample types analysed by end-users using PCR methods, each ranked according to their relative importance.
  •     Sample Preparation: The use of sample preparation methods by end-users for PCR studies, each ranked according to their importance.

Buy your copy of this report @ http://www.reportsnreports.com/reports/190676-pcr-2012-market-needs-emerging-developments-and-future-use.html

Browse More Reports on
Biotechnology
DNA Sequence

Contact sales (at) reportsandreports (dot) com for further information.

About US:
ReportsnReports.com (http://www.reportsnreports.com/) is an online market research reports library of 175,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.


Contact

Follow us on: Contact's Facebook Contact's Twitter Contact's LinkedIn Contact's Google Plus